Analystreport

Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at Canaccord Genuity Group Inc. to a "strong-buy" rating.

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com